Amgen Дивидендная доходность
Что обозначает Дивидендная доходность в Amgen?
Дивидендная доходность Amgen, Inc. является 3.01%
Какое определение для Дивидендная доходность?
Дивидендная доходность представляет собой соотношение между дивидендами, выплаченных акционерам на акцию, и рыночной ценой на акцию в течение последнего года.
The dividend yield or dividend-price ratio of a share is the dividend per share, divided by the price per share. It is also a company's total annual dividend payments divided by its market capitalization, assuming the number of shares is constant, and is often expressed as a percentage. The reciprocal of the dividend yield is the price-dividend ratio.
A higher dividend yield has been considered to be desirable among many investors. A high dividend yield can be considered to be evidence that a stock is underpriced or that the company has fallen on hard times and future dividends will not be as high as previous ones. Similarly a low dividend yield can be considered evidence that the stock is overpriced or that future dividends might be higher. Some investors may find a higher dividend yield attractive, for instance as an aid to marketing a fund to retail investors, or maybe because they cannot get their hands on the capital, which may be tied up in a trust arrangement. In contrast some investors may find a higher dividend yield unattractive, perhaps because it increases their tax bill.
Дивидендная доходность компаний в Health Care сектор на XETRA по сравнению с Amgen
Что делает Amgen?
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and a strategic research and development collaboration with Neumora Therapeutics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Компании с дивидендная доходность похож на Amgen
- Wienerberger AG имеет Дивидендная доходность из 3.00%
- Helmerich & Payne имеет Дивидендная доходность из 3.00%
- Yantai North Andre Juice имеет Дивидендная доходность из 3.00%
- First Pacific имеет Дивидендная доходность из 3.00%
- Ningbo Water Meter Co имеет Дивидендная доходность из 3.01%
- Tyson Foods имеет Дивидендная доходность из 3.01%
- Amgen имеет Дивидендная доходность из 3.01%
- Deutsche Bank AG имеет Дивидендная доходность из 3.01%
- CSR имеет Дивидендная доходность из 3.01%
- RSA Insurance plc 7.375% CUM IRR PRF GBP1 имеет Дивидендная доходность из 3.01%
- McCoy Global имеет Дивидендная доходность из 3.02%
- Macquarie имеет Дивидендная доходность из 3.02%
- Castrol India имеет Дивидендная доходность из 3.02%